Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies
Clinical trial NCT03447470 · COMPLETED
Trial details
- NCT number
- NCT03447470
- Sponsor
- Redx Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-18
- Primary completion
- 2023-09-29
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.